11 results
DEFA14A
GMDAQ
Gamida Cell Ltd
29 Sep 23
Additional proxy soliciting materials
8:41am
cell transplant with Omisirge. This is a significant milestone for Gamida Cell, marking the advancement of our mission of delivering potentially
8-K
EX-99.1
GMDAQ
Gamida Cell Ltd
27 Sep 23
Regulation FD Disclosure
4:43pm
-onlv).
“This is a significant milestone for Gamida Cell, advancing our mission of delivering potentially curative therapies to patients with cancer
8-K
EX-99.1
GMDAQ
Gamida Cell Ltd
14 Nov 22
Gamida Cell Reports Third Quarter 2022 Financial Results
7:15am
that leverage CAR- and CRISPR-mediated technologies. We are excited about the progress across our pipeline as we advance on our mission to deliver
8-K
EX-99.1
GMDAQ
Gamida Cell Ltd
19 Sep 22
Departure of Directors or Certain Officers
7:06am
Gamida Cell as we work to fulfill our mission of creating cures for blood cancers and serious hematologic diseases. Under Julian’s leadership, the team
8-K
EX-99.1
GMDAQ
Gamida Cell Ltd
15 Aug 22
Gamida Cell Reports Second Quarter 2022 Financial Results
7:15am
a new treatment option to tens of thousands of patients with relapsed/refractory lymphoma worldwide. We continue to execute our mission of advancing our
8-K
EX-99.1
b93lixlg
1 Aug 22
Gamida Cell Announces FDA Acceptance of
7:30am
8-K
EX-99.1
tjj 8odb2uvzk2yzr
2 Jun 22
Gamida Cell Completes
7:31am
8-K
EX-99.1
m5v6ktbq
31 Jan 22
Gamida Cell Announces Appointment of Anat Cohen-Dayag and Naama Halevi-Davidov to its Board of Directors
4:31pm
6-K
EX-99.1
djdy2g59mgtj
26 Oct 21
Gamida Cell to Present NAM-Enabled, Genetically Modified NK Cell Therapy Pipeline and Update on GDA-201 at Today’s Virtual R&D Day
7:30am
6-K
EX-99.1
17w12uq uace
13 Aug 21
Report of Foreign Private Issuer
4:04pm
6-K
EX-99.1
8tlnn
13 Oct 20
Gamida Cell and Be The Match BioTherapies® Expand Strategic Collaboration
8:21am
- Prev
- 1
- Next